 | Up a level |
Journal Article
Abrahamyan, S., Eberspaecher, B., Ambrosius, B., Hessler, N., Antony, G., Koenig, I. R., Hoshi, M. -M., Aly, L., Luessi, F., Groppa, S., Klotz, L., Meuth, S. G., Tackenberg, B., Stoppe, M., Bergh, F. Then, Tumani, H., Kuempfel, T., Stangel, M., Heesen, C., Wildemann, B., Paul, F., Bayas, A., Warnke, C., Weber, F., Linker, R. A., Ziemann, U., Zettl, U. K., Zipp, F., Wiendl, H., Hemmer, B., Gold, R., Salmen, A. and Ruprecht, K. (2018). Absence of Epstein-Barr virus seronegativity in a large cohort of patients with early multiple sclerosis. Mult. Scler. J., 24. S. 981 - 983. LONDON: SAGE PUBLICATIONS LTD. ISSN 1477-0970
Ambrosius, B., Hessler, N., Antony, G., Konig, I. R., Hoshi, M-M., Aly, L., Luessi, F., Groppa, S., Klotz, L., Meuth, S. G., Tackenberg, B., Stoppe, M., Bergh, F. Then, Tumani, H., Kuempfel, T., Stangel, M., Heesen, C., Wildemann, B., Paul, F., Bayas, A., Warnke, C., Weber, F., Linker, R. A., Ziemann, U., Zettl, U. K., Zipp, F., Wiendl, H., Hemmer, B., Gold, R. and Salmen, A. (2018). Changes of disease characteristics and disease-modifying treatment within one year in the National German MS cohort. Mult. Scler. J., 24. S. 554 - 557. LONDON: SAGE PUBLICATIONS LTD. ISSN 1477-0970
Heesen, C., Mokry, C., Salmen, A., Hegen, H., Maurer, M., Warnke, C., Gehring, K., Berthele, A. and Meier, U. (2022). German guideline for diagnosis and treatment of multiple sclerosis-a survey focusing neurologists in daily practise. Mult. Scler. Relat. Disord., 63. OXFORD: ELSEVIER SCI LTD. ISSN 2211-0356
Mokry, C., Warnke, C., Gehring, K., Hegen, H., Salmen, A., Kraemer, M., Kleiter, I, Fasshauer, E., Scheiderbauer, J., Luehmann, D., Koepke, S., Berthele, A. and Heesen, C. (2022). Implementation study of the 2021 German guideline for diagnosis and treatment of multiple sclerosis. Mult. Scler. Relat. Disord., 57. OXFORD: ELSEVIER SCI LTD. ISSN 2211-0356